Glibenclamide/metformin

From Wikipedia, the free encyclopedia
  (Redirected from Glucovance)
Jump to navigation Jump to search
Glibenclamide/metformin
Combination of
Glyburide (Glibenclamide)Sulfonylurea
MetforminBiguanide
Clinical data
Trade namesGlucovance
Other namesglyburide/metformin
AHFS/Drugs.comProfessional Drug Facts
MedlinePlusa699055
Pregnancy
category
  • AU: C
Routes of
administration
By mouth
ATC code
  • None
Legal status
Legal status
Identifiers
CAS Number
  • 338752-31-1
KEGG

Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It contains glibenclamide, a sulfonylureas, and metformin, a biguanide.[1]

References[edit]

  1. ^ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Retrieved 11 August 2020.

External links[edit]